A financial statement detailing investments in various biotech companies as of April 23, 2014, including trade dates, quantities, current prices, unit costs, market values, total costs, and unrealized gains/losses.
doj/DataSet10/EFTA01447223.pdf
{"document_date":"2014-04-23","document_type":"tabular","document_subtype":"financial statement","key_organizations":["Sangamo Biosciences","Biogen","Foundation Medicine","Gilead Sciences Inc","Ariad Pharmaceuticals"],"reference_numbers":["DB-SDNY-0101789","SDNY_GM_00247973","EFTA01447223"]}